Senolytic Therapeutics
About:
Senolytic Therapeutics (STX) is a pharmaceutical company that develops a novel class of medicines by targeting damaged cells.
Website: http://senolytx.com/
Top Investors: EASME - EU Executive Agency for SMEs
Description:
Senolytic Therapeutics is a operator of a pharmaceutical company intended to develop medicines and therapeutics for patients affected by age-related diseases. The company's medicines target and eliminate damaged cells, enabling healthcare providers to improve the lives of those affected by diseases associated with aging.
Total Funding Amount:
$583000
Headquarters Location:
Barcelona, Catalonia, Spain
Founded Date:
2017-01-01
Founders:
Marc Ramis Castelltort
Number of Employees:
1-10
Last Funding Date:
2018-08-01
IPO Status:
Private
Industries:
© 2025 bioDAO.ai